RT Journal Article
SR Electronic
T1 A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.19.20038182
DO 10.1101/2020.03.19.20038182
A1 Torneri, Andrea
A1 Libin, Pieter
A1 Vanderlocht, Joris
A1 Vandamme, Anne-Mieke
A1 Neyts, Johan
A1 Hens, Niel
YR 2020
UL http://medrxiv.org/content/early/2020/03/30/2020.03.19.20038182.abstract
AB Background Current outbreaks of COVID-19 are threatening the health care systems of several countries around the world. Control measures, based on isolation and quarantine, have been shown to decrease and delay the burden of the ongoing epidemic. With respect to the ongoing COVID-19 epidemic, recent modelling work shows that this intervention technique may be inadequate to control local outbreaks, even when perfect isolation is assumed. Furthermore, the effect of infectiousness prior to symptom onset combined with a significant proportion of asymptomatic infectees further complicates the use of contact tracing. Antivirals, which decrease the viral load and reduce the infectiousness, could be integrated in the control measures in order to augment the feasibility of controlling the epidemic.Methods Using a simulation-based model of viral transmission we tested the efficacy of different intervention measures for the control of COVID-19. For individuals that were identified through contact tracing, we evaluate two procedures: monitoring individuals for symptoms onset and testing of individuals. Moreover, we investigate the effect of a potent antiviral compound on the contact tracing process.Findings The use of an antiviral drug, in combination with contact tracing, quarantine and isolation, results in a significant decrease of the final size, the peak incidence, and increases the probability that the outbreak will fade out.Interpretation For an infectious disease in which presymptomatic infections are plausible, an intervention measure based on contact tracing performs better when realized together with testing instead of monitoring, provided that the test is able to detect infections during the incubation period. In addition, in all tested scenarios, the model highlights the benefits of the administration of an antiviral drug in addition to quarantine, isolation and contact tracing. The resulting control measure, could be an effective strategy to control local and re-emerging out-breaks of COVID-19.Competing Interest StatementBesides his employment at the Hasselt University, JV is employed at Bioqube Ventures. Bioqube Ventures was not involved in this work, nor does it prosper financially as a result of the current study. The other authors declare that they have no competing interests.Funding StatementThis work is funded by the Epipose project from the European Union’s SC1-PHE-CORONAVIRUS-2020 programme, project number 101003688 and by the European Union’s Horizon 2020 research and innovation programme (grant agreement 682540 — TransMID). AT acknowledges support from the special research fund of the University of Antwerp. PL was supported by funding from the Flemish Government under the “Onderzoeksprogramma Artificiele Intelligentie (AI) Vlaanderen” programme.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur study concerns the modelling of antiviral compounds to contain COVID-19 epidemics. Our modelling code has been posted to github. https://github.com/AndreaTorneri/ViralTransm